| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/04/2001 | CA2404049A1 Treatment of movement disorders |
| 10/04/2001 | CA2403909A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 10/04/2001 | CA2403906A1 Pharmaceutical compositions containing oligosaccharides and preparation thereof |
| 10/04/2001 | CA2403857A1 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 10/04/2001 | CA2403814A1 Polyamine analogues as cytotoxic agents |
| 10/04/2001 | CA2403800A1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 10/04/2001 | CA2403787A1 Il-8 receptor antagonists |
| 10/04/2001 | CA2403557A1 Crystalline form vii of cabergoline |
| 10/04/2001 | CA2403555A1 Methods for effecting neuroprotection |
| 10/04/2001 | CA2403297A1 Docosahexaenoic acid as retinoid x receptor and uses thereof |
| 10/04/2001 | CA2402769A1 Ceramide derivatives and method of use |
| 10/04/2001 | CA2402613A1 Cationic liposomes |
| 10/04/2001 | CA2402472A1 2,3,4,5-tetrahydro-1h-¬1,4|diazepino¬1,7a|indole compounds |
| 10/04/2001 | CA2402439A1 Methods of modulating drug clearance mechanisms by altering sxr activity |
| 10/04/2001 | CA2402288A1 Naphtalene derivatives and their pharmaceutical use |
| 10/04/2001 | CA2402187A1 Intracorporeal medicaments comprising halogenated xanthene for photodynamic treatment of disease |
| 10/04/2001 | CA2401748A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders |
| 10/04/2001 | CA2401242A1 Pharmaceutically active pyrrolidine derivatives |
| 10/04/2001 | CA2400573A1 Alteration of cellular behavior by antisense modulation of mrna processing |
| 10/04/2001 | CA2399864A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases |
| 10/04/2001 | CA2399540A1 Crystalline form ii of cabergoline |
| 10/04/2001 | CA2399287A1 Beta-glucans from filamentous fungi |
| 10/04/2001 | CA2374731A1 Agent for modulating growth or generation of hair |
| 10/03/2001 | CN1316001A Polyketides and their synthesis |
| 10/03/2001 | CN1315965A Hepatitis C inhibitor peptides |
| 10/03/2001 | CN1315956A Polyketides and their synthesis |
| 10/03/2001 | CN1315954A Substituted benzimidazoles, production and use thereof as agents for combating parasitic protozoas |
| 10/03/2001 | CN1315951A FKBP inhibitors |
| 10/03/2001 | CN1315950A Dihydrobenzodioxine carboxamide and ketone derivatives as 5-HT4 receptor antagonists |
| 10/03/2001 | CN1315949A Salts of paroxetine |
| 10/03/2001 | CN1315945A Nitrate salts of antihypertensive medicines |
| 10/03/2001 | CN1315942A 2-oxo-j(2H)-quinoline derivatives |
| 10/03/2001 | CN1315936A Compounds and compositions for delivering active agents |
| 10/03/2001 | CN1315873A Prevention/remedies for multiple organ failure |
| 10/03/2001 | CN1315863A Use of rosmarinic acid and derivatives thereof as immunosuppressant or inhibitor of SHz-mediated process |
| 10/03/2001 | CN1315862A Medicinal compositions for treating eye diseases |
| 10/03/2001 | CN1315861A Use of R(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for treatment of sleep disorders |
| 10/03/2001 | CN1315860A Method for treating hot flashes in humans |
| 10/03/2001 | CN1315859A Substances having antiobese and visceral fat-reducing functions and utilization thereof |
| 10/03/2001 | CN1315858A Novel remedies for allergic diseases |
| 10/03/2001 | CN1315857A Method of rearing and feeds |
| 10/03/2001 | CN1315856A Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 10/03/2001 | CN1315855A Immediate release tablet |
| 10/03/2001 | CN1315854A Microparticles |
| 10/03/2001 | CN1315853A Bioenhanced formulations comprising eprosartan in oral dosage form |
| 10/03/2001 | CN1315852A Medicinal aerosol formulations |
| 10/03/2001 | CN1315851A Oral care compositions |
| 10/03/2001 | CN1315835A Antioxidant composition comprising acetyl L-carnitine and alpha-lipoic acid |
| 10/03/2001 | CN1315830A Treatment of anxiety disorders |
| 10/03/2001 | CN1315458A Low-molecular heparin and its preparing process |
| 10/03/2001 | CN1315326A Cisplatinun dinuclear platinum complex for treating cancer and its therapeutic method |
| 10/03/2001 | CN1315320A Ether and amide compounds as medicide for treating glycuresis and preparing process thereof |
| 10/03/2001 | CN1315319A Process for preparing ethyl-sulfonylpiperidine derivatives |
| 10/03/2001 | CN1315208A 166 HO-DTPA, its preparing method and application as liquid radiation source |
| 10/03/2001 | CN1315202A Ointment for treating psoriasis |
| 10/03/2001 | CN1315201A Ointment for treating acne |
| 10/03/2001 | CN1315200A Exterior-applied medicine for treating lumbar intervertebral disk protrusion |
| 10/03/2001 | CN1315199A Medicine for regulating blood fat and reducing plasma fibrin |
| 10/03/2001 | CN1315179A Application of aminoaglycon antibiotics in preparing compound oral liquid for treating gastroenteritis |
| 10/03/2001 | CN1315178A Compound sodium salicylate tablet |
| 10/03/2001 | CN1315177A Method for curing sexual dysfunction by specific blood plasma concentration apomorphine |
| 10/03/2001 | CN1315176A Application of bilirubin bitaurine sodium and its bilirubin derivative in preparing anti-HIV medicine |
| 10/03/2001 | CN1315175A Process for preparing ginkgolide injection |
| 10/03/2001 | CN1315174A Composite medicine for treating renale failure |
| 10/03/2001 | CN1072229C Maltitol composition and method for preparing same |
| 10/03/2001 | CN1072224C Condensed 'beta'-carbolines |
| 10/03/2001 | CN1072222C Phenyloxazolidinones having C-C bond to 4-8 membered heterocyclic rings |
| 10/03/2001 | CN1072220C 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derives as neurokinin receptor antagonists |
| 10/03/2001 | CN1072214C Biologically active benzothiazolone ethanamines |
| 10/03/2001 | CN1072210C 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors |
| 10/03/2001 | CN1072209C Benzonitriles and benzofluorides |
| 10/03/2001 | CN1072206C Amide derivatives and external skin or hair care prepn. |
| 10/03/2001 | CN1072013C Process for preparing preparation containing high content of alpha-linolenic acid |
| 10/03/2001 | CN1072012C Process for extracting danshensu from red sage root and protocatechualdehyde |
| 10/03/2001 | CN1071992C Ionene polymers as microbicides |
| 10/03/2001 | CA2343452A1 Method of treating a parasitic infection |
| 10/02/2001 | US6297399 Hypotensive agents |
| 10/02/2001 | US6297381 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor, ureas or thioureas substituted by a pyrrole or thiophene |
| 10/02/2001 | US6297379 Thienopyrimidine compounds, their production and use |
| 10/02/2001 | US6297376 Potent and selective substance p (or neurokinin-1) receptor antagonists. one-step alkylation with 3-chloromethyl-1,2,4-triazolin-5-one, |
| 10/02/2001 | US6297375 4-phenyl-pyridine derivatives |
| 10/02/2001 | US6297371 Cytolysing raw cells, applying to anion exchanger which begins desorbing dna and rna at different ionic strengths, then eluting nucleic acids and/or oligonucleotides; treating preparation at first or last step to remove endotoxin |
| 10/02/2001 | US6297363 3-o-beta-d-glucopyranosyl(1-6)-beta-d-glucopyranosyl indole; isolated from calanthe discolor lindl; for promotion of hair growth and restoration |
| 10/02/2001 | US6297290 Composition containing a nerve fiber reactivity modulating compound |
| 10/02/2001 | US6297289 Dispenser for introducing microscopic particles of propanethial-s-oxide into the eye |
| 10/02/2001 | US6297288 Administering an effective amount of adrenergic stimulant |
| 10/02/2001 | US6297287 Substituted trialkylenetetramines or n,n'-bis(pyridinylalkyl)alkylenediamines |
| 10/02/2001 | US6297286 Administering single enantiomer (-) tramadol or a metabolite for nausea, vomiting, dizziness, blurred vision, drowsiness, somnolence, hallucinations, respiratory depression, constipation and euphoria. |
| 10/02/2001 | US6297284 Aza-enediyne, aza-enyne allene, or an aza-diallene cationic compounds that bind to nucleic acids. |
| 10/02/2001 | US6297282 Substituted derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase II |
| 10/02/2001 | US6297281 Association of no syntase inhibitors with trappers of oxygen reactive forms |
| 10/02/2001 | US6297280 Theanine, and one or more compounds selected from the group consisting of cholines, arachidonic acid, eicoapentaenoic acid (epa) and docosahexaenoic acid (dha). |
| 10/02/2001 | US6297278 Low cytotoxicity synergistic mixture of a betaine, an amine oxide and an acid in an amount to provide the composition with a ph of 4-8 |
| 10/02/2001 | US6297277 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 10/02/2001 | US6297276 Substituted urea and isothiourea derivatives as no synthase inhibitors |
| 10/02/2001 | US6297273 Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions |
| 10/02/2001 | US6297271 Controlling take-all disease in a plant |
| 10/02/2001 | US6297269 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
| 10/02/2001 | US6297268 E.g., n-(m-(methoxyphenyl))-n'-(p-(imidazol-3-ylmethyl)benzyl)urea |
| 10/02/2001 | US6297267 Prostaglandin i2 agonist. |